Su447 USTEKINUMAB LEVELS DEPEND ON INDUCTION FECAL CALPROTECTIN DROP-SLOPE AND CAN DISCRIMINATE THE NEED OF INTENSIFICATION AT WEEK 52 IN CROHN'S DISEASE PATIENTS | Publicación